Wahid B, Shami K, Joiya SA, Ozuyar SEG, et al. Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin). J Med Virol 2020 May 17. doi: 10.1002/jmv.25931.
PMID: 32419178